Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 19/20 | 0.37 |
| ▸ | CNR1 | P21554 | 2/20 | 0.31 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19713743 | 0.93 | GABRA1 (0.34) | CNR2CNR1 | |
| SCHEMBL19713977 | 0.93 | GABRA1 (0.34) | CNR2CNR1 | |
| SCHEMBL17777102 | 0.93 | GABRA1 (0.34) | CNR2CNR1 | |
| SCHEMBL19713744 | 0.93 | GABRA1 (0.34) | CNR2CNR1 | |
| SCHEMBL20720998 | 0.90 | CNR2 (0.35) | CNR2CNR1 | |
| SCHEMBL20721049 | 0.90 | CNR2 (0.35) | CNR2CNR1 | |
| SCHEMBL19736200 | 0.90 | CNR2 (0.38) | CNR2CNR1CXCR3 | |
| SCHEMBL19736296 | 0.86 | CNR2 (0.37) | CNR2CNR1CXCR3 | |
| SCHEMBL19713929 | 0.83 | CNR2 (0.36) | CNR2CNR1 | |
| SCHEMBL19713927 | 0.83 | CNR2 (0.36) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362234-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362234-A1 | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS | SIRT1, SIRT3, SIRT2 | CNR2 3062/4885CNR1 3100/4885CXCR3 4621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.